DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Behavioral: CONNECT platform

First Posted Date: 2024-07-01

Last Posted Date: 2024-08-20

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 375

Registration Number: NCT06481774

Locations: 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

Phase 1

Not yet recruiting

Conditions: Brain Tumor
Glioblastoma

Interventions: Other: Control Group - Standard of care neurosurgical resection
Procedure: MRF/MRI infiltration guidance for extended resection

First Posted Date: 2024-06-12

Last Posted Date: 2025-02-12

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 114

Registration Number: NCT06455189

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, UH Department of Radiology, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer

Not Applicable

Recruiting

Conditions: Malignant Neoplasm
Cancer

Interventions: Device: Virtual Reality
Other: Preferred activity
Other: Questionnaires

First Posted Date: 2024-06-06

Last Posted Date: 2024-11-12

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 70

Registration Number: NCT06446115

Locations: 🇺🇸
Cleveland Clinic Florida, Maroone Cancer Center, Weston, Florida, United States

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Behavioral: Expanded Prostate Cancer Index Composite and Decision Regret Scale

First Posted Date: 2024-05-30

Last Posted Date: 2024-11-01

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 288

Registration Number: NCT06435871

Locations: 🇺🇸
Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

Not Applicable

Recruiting

Conditions: Acute Leukemia
Acute Myeloid Leukemia in Children
Myeloproliferative Neoplasm
Acute Lymphoblastic Leukemia, Pediatric

Interventions: Other: MRF with neurocognative studies

First Posted Date: 2024-05-20

Last Posted Date: 2025-05-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06421155

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Rainbow Babies & Children's Hospital, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Phase 1

Recruiting

Conditions: Pancreatic Adenocarcinoma
Ovarian Cancer
Epithelial Ovarian Cancer

Interventions: Other: Prehabilitation

First Posted Date: 2024-05-14

Last Posted Date: 2025-03-05

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 22

Registration Number: NCT06412510

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Not Applicable

Recruiting

Conditions: Epithelial Ovarian Cancer

Interventions: Behavioral: Intermittent Fasting
Drug: Neoadjuvant chemotherapy

First Posted Date: 2024-04-26

Last Posted Date: 2025-01-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06386887

Locations: 🇺🇸
Department of Subspecialty Care for Women's Health Women's Health; Division of Gynecologic Oncology, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Phase 1

Withdrawn

Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck
Metastatic Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: INQOVI (decitabine and cedazuridine)
Drug: Nivolumab

First Posted Date: 2024-04-10

Last Posted Date: 2024-07-03

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT06357858

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Linking Somatic Mutation Rate With Baseline Exposure in East Palestine

Not Applicable

Recruiting

Conditions: Somatic Mutation

Interventions: Other: Survey
Other: Biological specimen collection
Other: Communications about study updates and future research opportunities
Other: Qualitative interview

First Posted Date: 2024-04-10

Last Posted Date: 2024-12-04

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 500

Registration Number: NCT06357845

Locations: 🇺🇸
Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Not Applicable

Recruiting

Conditions: Cancer Pain
Oncology Pain

Interventions: Other: Reiki

First Posted Date: 2024-04-09

Last Posted Date: 2025-01-22

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06354049

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy